Table 1. Subject demographic data... | American Society of Hematology

Table 1.

Subject demographic data

Subject ID	Age (years)	Sex	Race	Age at diagnosis	Previous treatment type	Dosing cohort, U/kg	Platelet levels at screening (10⁹/L)	LDH levels at screening (U/L)
1	22	F	White	15	Prophylaxis	5	106*	294*
2	28	M	White	24	On Demand	5	166	136
3	35	M	White	29	Prophylaxis	20	154	170
4	21	F	Asian	<1	Prophylaxis	40	167	151
5	24	F	Asian	17	Prophylaxis	20	220	142
6	25	M	White	2	Prophylaxis	40	190†	159
7	33	F	White	20	Prophylaxis	40	223	165
8	32	F	White	10	On Demand	40	221	146
9	40	M	White	16	Prophylaxis	40	216	125
10	41	F	White	19	On Demand	5	348	130
11	39	F	White	36	Prophylaxis	20	252	259*
12	16	M	White	14	Prophylaxis	40	214	153
13	17	F	White	<1	Prophylaxis	40	353	140
14	33	M	White	26	Prophylaxis	40	273	122†
15	30	M	Black	14	Prophylaxis	40	297	185

Subject ID	Age (years)	Sex	Race	Age at diagnosis	Previous treatment type	Dosing cohort, U/kg	Platelet levels at screening (10⁹/L)	LDH levels at screening (U/L)
1	22	F	White	15	Prophylaxis	5	106*	294*
2	28	M	White	24	On Demand	5	166	136
3	35	M	White	29	Prophylaxis	20	154	170
4	21	F	Asian	<1	Prophylaxis	40	167	151
5	24	F	Asian	17	Prophylaxis	20	220	142
6	25	M	White	2	Prophylaxis	40	190†	159
7	33	F	White	20	Prophylaxis	40	223	165
8	32	F	White	10	On Demand	40	221	146
9	40	M	White	16	Prophylaxis	40	216	125
10	41	F	White	19	On Demand	5	348	130
11	39	F	White	36	Prophylaxis	20	252	259*
12	16	M	White	14	Prophylaxis	40	214	153
13	17	F	White	<1	Prophylaxis	40	353	140
14	33	M	White	26	Prophylaxis	40	273	122†
15	30	M	Black	14	Prophylaxis	40	297	185

Table has been anonymized by permutation of the following columns: age and age at diagnosis.

Abnormal.

Baseline values provided; screening values not available.